Dimensional Fund Advisors LP boosted its position in shares of Avanos Medical, Inc. (NYSE:AVNS – Get Rating) by 2.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,891,836 shares of the company’s stock after buying an additional 64,029 shares during the quarter. Dimensional Fund Advisors LP owned 0.06% of Avanos Medical worth $78,254,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Avanos Medical by 2.2% during the first quarter. Vanguard Group Inc. now owns 5,334,332 shares of the company’s stock worth $178,700,000 after buying an additional 112,546 shares during the period. State Street Corp boosted its stake in Avanos Medical by 0.5% during the first quarter. State Street Corp now owns 2,018,705 shares of the company’s stock worth $67,627,000 after buying an additional 9,410 shares during the period. Goldman Sachs Group Inc. boosted its stake in Avanos Medical by 24.5% during the first quarter. Goldman Sachs Group Inc. now owns 1,998,871 shares of the company’s stock worth $66,962,000 after buying an additional 392,870 shares during the period. Neuberger Berman Group LLC boosted its stake in Avanos Medical by 5.4% during the third quarter. Neuberger Berman Group LLC now owns 870,524 shares of the company’s stock worth $18,980,000 after buying an additional 44,361 shares during the period. Finally, Northern Trust Corp boosted its stake in Avanos Medical by 4.9% during the second quarter. Northern Trust Corp now owns 670,171 shares of the company’s stock worth $18,322,000 after buying an additional 31,462 shares during the period. 92.08% of the stock is owned by hedge funds and other institutional investors.
Avanos Medical Stock Performance
AVNS stock opened at $22.72 on Thursday. The company has a debt-to-equity ratio of 0.16, a current ratio of 2.86 and a quick ratio of 1.60. The business has a 50-day moving average price of $27.55 and a 200 day moving average price of $27.81. The company has a market capitalization of $1.06 billion, a P/E ratio of 24.70 and a beta of 0.93. Avanos Medical, Inc. has a 1-year low of $19.32 and a 1-year high of $31.99.
Analyst Upgrades and Downgrades
AVNS has been the subject of a number of recent analyst reports. CL King initiated coverage on shares of Avanos Medical in a research note on Monday. They set a “buy” rating and a $31.00 target price for the company. TheStreet lowered shares of Avanos Medical from a “b-” rating to a “c” rating in a research note on Wednesday, May 3rd. StockNews.com initiated coverage on shares of Avanos Medical in a research note on Thursday, May 18th. They set a “buy” rating for the company. Finally, Morgan Stanley boosted their target price on shares of Avanos Medical from $26.00 to $28.00 and gave the company an “underweight” rating in a research note on Wednesday, February 22nd. One equities research analyst has rated the stock with a sell rating and three have issued a buy rating to the stock. According to data from MarketBeat, Avanos Medical presently has an average rating of “Moderate Buy” and a consensus target price of $30.25.
About Avanos Medical
Avanos Medical, Inc is a medical technology company. It engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
- Get a free copy of the StockNews.com research report on Avanos Medical (AVNS)
- Toll Brothers Rises On Results, But The Roof Is In Place
- It’s Time To Try On VF Corporation’s 6% Yield
- PetCo Management Getting it Right? Earnings Beat Says Yes
- Axcelis Stock In Buy Range After Chart Breakout, Strong Guidance
- Kohl’s 10% Yield Comes Into High Fashion
Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNS – Get Rating).
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.